Mice were trained to avoid electric shocks by means of step-down type passive avoidance learning tasks, and memory retention was measured 24 h after the training session. Memory impairment (
amnesia) was produced by administering either
p-chloroamphetamine (PCA), a
serotonin (5-HT) releaser or
scopolamine (SCOP), a
muscarinic cholinoceptor antagonist, 30 min prior to the training session.
Benzomorphans, 5-HT2 antagonists and
acetylcholinesterase (AChE) inhibitors were administered immediately after the training session. PCA- but not SCOP-induced
amnesia was attenuated by the post-training administration of two
benzomorphans, (+)
N-allylnormetazocine ((+)SKF-10,047) and (+/- )
pentazocine ((+/- )PTZ). Similarly, PCA-induced
amnesia was reversed by the post-training administration of 5-HT2 antagonists,
ritanserin (RIT) and
mianserin (MIA), but SCOP-induced
amnesia was not. However, the AChE inhibitors,
tetrahydroaminoacridine (THA) and
physostigmine (PHY) attenuated both PCA- and SCOP-induced
amnesia when administered immediately after the training session. These results indicated that
benzomorphans and 5-HT2 antagonists have antiamnestic effects in mice, as do AChE inhibitors. In addition, it is interesting that the patterns of ameliorating effect of
benzomorphans were similar to those of 5-HT2 antagonists, which differ from those of AChE inhibitors.